Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Volatile Organic Compound (VOC)-Based Probe for Induced Volatolomics of Cancers.

Lange J, Eddhif B, Tarighi M, Garandeau T, Péraudeau E, Clarhaut J, Renoux B, Papot S, Poinot P.

Angew Chem Int Ed Engl. 2019 Sep 13. doi: 10.1002/anie.201906261. [Epub ahead of print]

PMID:
31518472
2.

The Lossen rearrangement from free hydroxamic acids.

Thomas M, Alsarraf J, Araji N, Tranoy-Opalinski I, Renoux B, Papot S.

Org Biomol Chem. 2019 Jun 5;17(22):5420-5427. doi: 10.1039/c9ob00789j. Review.

PMID:
31090777
3.

Function-Oriented Synthesis toward Peloruside A Analogues.

Chany AC, Legros F, Haroun H, Kundu UK, Biletskyi B, Torlak S, Mathé-Allainmat M, Lebreton J, Macé A, Carboni B, Renoux B, Gosselin P, Dujardin G, Gaulon-Nourry C.

Org Lett. 2019 May 3;21(9):2988-2992. doi: 10.1021/acs.orglett.9b00413. Epub 2019 Mar 12.

PMID:
30859834
4.

Controlled Release of a Micelle Payload via Sequential Enzymatic and Bioorthogonal Reactions in Living Systems.

Porte K, Renoux B, Péraudeau E, Clarhaut J, Eddhif B, Poinot P, Gravel E, Doris E, Wijkhuisen A, Audisio D, Papot S, Taran F.

Angew Chem Int Ed Engl. 2019 May 6;58(19):6366-6370. doi: 10.1002/anie.201902137. Epub 2019 Mar 29.

PMID:
30856679
5.

A β-glucuronidase-responsive albumin-binding prodrug programmed for the double release of monomethyl auristatin E.

Renoux B, Fangous L, Hötten C, Péraudeau E, Eddhif B, Poinot P, Clarhaut J, Papot S.

Medchemcomm. 2018 Oct 26;9(12):2068-2071. doi: 10.1039/c8md00466h. eCollection 2018 Dec 1.

PMID:
30746064
6.

A β-glucuronidase-responsive albumin-binding prodrug for potential selective kinase inhibitor-based cancer chemotherapy.

Compain G, Oumata N, Clarhaut J, Péraudeau E, Renoux B, Galons H, Papot S.

Eur J Med Chem. 2018 Oct 5;158:1-6. doi: 10.1016/j.ejmech.2018.08.100. Epub 2018 Sep 3.

PMID:
30199702
7.

Reduction-rebridging strategy for the preparation of ADPN-based antibody-drug conjugates.

Koniev O, Dovgan I, Renoux B, Ehkirch A, Eberova J, Cianférani S, Kolodych S, Papot S, Wagner A.

Medchemcomm. 2018 Apr 20;9(5):827-830. doi: 10.1039/c8md00141c. eCollection 2018 May 1.

8.

Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid.

Péraudeau E, Cronier L, Monvoisin A, Poinot P, Mergault C, Guilhot F, Tranoy-Opalinski I, Renoux B, Papot S, Clarhaut J.

J Control Release. 2018 Jan 10;269:36-44. doi: 10.1016/j.jconrel.2017.11.011. Epub 2017 Nov 10.

PMID:
29129656
9.

Development and evaluation of β-galactosidase-sensitive antibody-drug conjugates.

Kolodych S, Michel C, Delacroix S, Koniev O, Ehkirch A, Eberova J, Cianférani S, Renoux B, Krezel W, Poinot P, Muller CD, Papot S, Wagner A.

Eur J Med Chem. 2017 Dec 15;142:376-382. doi: 10.1016/j.ejmech.2017.08.008. Epub 2017 Aug 4.

PMID:
28818506
10.

Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers.

Renoux B, Raes F, Legigan T, Péraudeau E, Eddhif B, Poinot P, Tranoy-Opalinski I, Alsarraf J, Koniev O, Kolodych S, Lerondel S, Le Pape A, Clarhaut J, Papot S.

Chem Sci. 2017 May 1;8(5):3427-3433. doi: 10.1039/c7sc00472a. Epub 2017 Mar 8.

11.

In situ targeted activation of an anticancer agent using ultrasound-triggered release of composite droplets.

Bezagu M, Clarhaut J, Renoux B, Monti F, Tanter M, Tabeling P, Cossy J, Couture O, Papot S, Arseniyadis S.

Eur J Med Chem. 2017 Dec 15;142:2-7. doi: 10.1016/j.ejmech.2017.03.057. Epub 2017 Mar 28.

PMID:
28416362
12.

A dendritic β-galactosidase-responsive folate-monomethylauristatin E conjugate.

Alsarraf J, Péraudeau E, Poinot P, Tranoy-Opalinski I, Clarhaut J, Renoux B, Papot S.

Chem Commun (Camb). 2015 Nov 11;51(87):15792-5. doi: 10.1039/c5cc05294g.

PMID:
26365722
13.

A mechanically interlocked molecular system programmed for the delivery of an anticancer drug.

Barat R, Legigan T, Tranoy-Opalinski I, Renoux B, Péraudeau E, Clarhaut J, Poinot P, Fernandes AE, Aucagne V, Leigh DA, Papot S.

Chem Sci. 2015 Apr 1;6(4):2608-2613. doi: 10.1039/c5sc00648a. Epub 2015 Feb 25.

14.

Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumors.

Bensalma S, Chadeneau C, Legigan T, Renoux B, Gaillard A, de Boisvilliers M, Pinet-Charvet C, Papot S, Muller JM.

J Mol Neurosci. 2015 Jan;55(1):51-61. doi: 10.1007/s12031-014-0395-3. Epub 2014 Oct 4.

PMID:
25280457
15.

Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma.

Balbous A, Renoux B, Cortes U, Milin S, Guilloteau K, Legigan T, Rivet P, Boissonnade O, Martin S, Tripiana C, Wager M, Bensadoun RJ, Papot S, Karayan-Tapon L.

Mol Cancer Ther. 2014 Sep;13(9):2159-69. doi: 10.1158/1535-7163.MCT-13-1038. Epub 2014 Jul 22.

16.

β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an update.

Tranoy-Opalinski I, Legigan T, Barat R, Clarhaut J, Thomas M, Renoux B, Papot S.

Eur J Med Chem. 2014 Mar 3;74:302-13. doi: 10.1016/j.ejmech.2013.12.045. Epub 2014 Jan 11.

PMID:
24480360
17.

An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification process.

Grinda M, Legigan T, Clarhaut J, Peraudeau E, Tranoy-Opalinski I, Renoux B, Thomas M, Guilhot F, Papot S.

Org Biomol Chem. 2013 Nov 7;11(41):7129-33. doi: 10.1039/c3ob41536h.

PMID:
24057011
18.

Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy.

Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Jayle C, Alsarraf J, Thomas M, Papot S.

Eur J Med Chem. 2013 Sep;67:75-80. doi: 10.1016/j.ejmech.2013.06.037. Epub 2013 Jun 25.

PMID:
23845743
19.

A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts.

Clarhaut J, Fraineau S, Guilhot J, Peraudeau E, Tranoy-Opalinski I, Thomas M, Renoux B, Randriamalala E, Bois P, Chatelier A, Monvoisin A, Cronier L, Papot S, Guilhot F.

Leuk Res. 2013 Aug;37(8):948-55. doi: 10.1016/j.leukres.2013.04.026. Epub 2013 May 28.

PMID:
23726264
20.

The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy.

Legigan T, Clarhaut J, Tranoy-Opalinski I, Monvoisin A, Renoux B, Thomas M, Le Pape A, Lerondel S, Papot S.

Angew Chem Int Ed Engl. 2012 Nov 12;51(46):11606-10. doi: 10.1002/anie.201204935. Epub 2012 Sep 20.

PMID:
22996951
21.

Synthesis and antitumor efficacy of a β-glucuronidase-responsive albumin-binding prodrug of doxorubicin.

Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Berjeaud JM, Guilhot F, Papot S.

J Med Chem. 2012 May 10;55(9):4516-20. doi: 10.1021/jm300348r. Epub 2012 Apr 30.

PMID:
22515366
22.

A new cyclopamine glucuronide prodrug with improved kinetics of drug release.

Renoux B, Legigan T, Bensalma S, Chadéneau C, Muller JM, Papot S.

Org Biomol Chem. 2011 Dec 21;9(24):8459-64. doi: 10.1039/c1ob06081c. Epub 2011 Oct 31.

PMID:
22042246
23.

A heterodimeric glucuronide prodrug for cancer tritherapy: the double role of the chemical amplifier.

Grinda M, Clarhaut J, Tranoy-Opalinski I, Renoux B, Monvoisin A, Cronier L, Papot S.

ChemMedChem. 2011 Dec 9;6(12):2137-41. doi: 10.1002/cmdc.201100355. Epub 2011 Aug 3. No abstract available.

PMID:
21815268
24.

Evidence of a pharmacodynamic EEG profile in rats following clonidine administration using a nonlinear analysis.

Azulay DO, Renoux B, Ivarsson M.

Nonlinear Biomed Phys. 2011 Jun 26;5(1):4. doi: 10.1186/1753-4631-5-4.

25.

Study of a cyclopamine glucuronide prodrug for the selective chemotherapy of glioblastoma.

Hamon F, Renoux B, Chadéneau C, Muller JM, Papot S.

Eur J Med Chem. 2010 Apr;45(4):1678-82. doi: 10.1016/j.ejmech.2009.12.067. Epub 2010 Jan 13.

PMID:
20116904
26.

Synthesis of 3-vinyl-2,5-dihydrofuran ring system via enyne metathesis.

Vuong S, Rodriguez-Fernandez MM, Renoux B, Len C.

Carbohydr Res. 2010 Jan 26;345(2):324-9. doi: 10.1016/j.carres.2009.09.023. Epub 2009 Sep 26.

PMID:
19939351
27.

Gem-difluorination of aminoalkynes via highly reactive dicationic species in superacid HF-SbF5: application to the efficient synthesis of difluorinated cinchona alkaloid derivatives.

Cantet AC, Carreyre H, Gesson JP, Jouannetaud MP, Renoux B.

J Org Chem. 2008 Apr 4;73(7):2875-8. doi: 10.1021/jo702441p. Epub 2008 Mar 4.

PMID:
18315004
28.

Total synthesis and conformational analysis of the antifungal agent (-)-PF1163B.

Bouazza F, Renoux B, Bachmann C, Gesson JP.

Org Lett. 2003 Oct 30;5(22):4049-52. Erratum in: Org Lett. 2004 Mar 18;6(6):1069.

PMID:
14572246
29.

New cytotoxic analogues of annonaceous acetogenins.

Rodier S, Le Huerou Y, Renoux B, Doyon J, Renard P, Pierré A, Gesson JP, Grée R.

Anticancer Drug Des. 2001 Apr-Jun;16(2-3):109-17.

PMID:
11962508
30.

Synthesis and cytotoxic activity of tetracenomycin D and of saintopin analogues.

Martin P, Rodier S, Mondon M, Renoux B, Pfeiffer B, Renard P, Pierré A, Gesson JP.

Bioorg Med Chem. 2002 Feb;10(2):253-60.

PMID:
11741773
31.

Synthesis and cytotoxic activity of acetogenin analogues.

Rodier S, Le Huérou Y, Renoux B, Doyon J, Renard P, Pierré A, Gesson JP, Grée R.

Bioorg Med Chem Lett. 2000 Jun 19;10(12):1373-5.

PMID:
10890167
32.

Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.

Florent JC, Dong X, Gaudel G, Mitaku S, Monneret C, Gesson JP, Jacquesy JC, Mondon M, Renoux B, Andrianomenjanahary S, Michel S, Koch M, Tillequin F, Gerken M, Czech J, Straub R, Bosslet K.

J Med Chem. 1998 Sep 10;41(19):3572-81.

PMID:
9733483
33.

Prodrugs of anthracyclines for chemotherapy via enzyme-monoclonal antibody conjugates.

Gesson JP, Jacquesy JC, Mondon M, Petit P, Renoux B, Andrianomenjanahary S, Dufat-Trinh Van H, Koch M, Michel S, Tillequin F, et al.

Anticancer Drug Des. 1994 Oct;9(5):409-23.

PMID:
7945725
34.

[Duodenal stenosis disclosing rheumatoid purpura in an adult].

Herbault GF, Harle JR, Renoux B, Orfanos J, Jean E.

J Chir (Paris). 1988 Feb;125(2):136-7. French. No abstract available.

PMID:
3366815
35.

[Lipoma of the colon].

Herbault GF, Renoux B, Jean E.

Ann Gastroenterol Hepatol (Paris). 1987 Jan-Feb;23(1):11-4. French.

PMID:
3579215
36.

[Diastatic perforations of the colon of neoplastic origin. Apropos of 15 cases].

Renoux B, Herbault GF, Jean E.

J Chir (Paris). 1986 Nov;123(11):644-50. French.

PMID:
3611221
37.

[Bile ileus. The place of non-surgical treatment].

Renoux B, Herbault GF, Manoli P, Jean E.

Presse Med. 1986 Sep 6;15(28):1331-2. French. No abstract available.

PMID:
2950400
38.

[Factors in recurrence of perforated duodenal ulcer after simple suture. Therapeutic deductions].

Herbault GF, Renoux B, Carrelet T, Darmon M, Jean E.

J Chir (Paris). 1985 Dec;122(12):675-80. French.

PMID:
3910666

Supplemental Content

Loading ...
Support Center